Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 2/2017

01-04-2017 | Novel Aspects in Lupus, 2017

The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome

Authors: Jovica Saponjski, Ljudmila Stojanovich, Jelena Petrovic, Dusan Saponjski

Published in: Immunologic Research | Issue 2/2017

Login to get access

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease which is characterized by arterial and venous thromboses, fetal loss, and the presence of antiphospholipid antibodies in the serum. It is characterized by accelerated atherosclerosis. Increased tendency towards thrombosis leads to the occurrence of various vascular events. The objective of our study was to determine if there are subclinical changes on lower limb arteries in APS patients and what the best diagnostic choice for their establishment is. In this study, we analyzed 50 patients with primary antiphospholipid syndrome (PAPS) and 50 patients, who have secondary antiphospholipid syndrome (SAPS). The results were compared to 50 controls. The groups were comparable with respect to age, gender, and traditional risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. Study was conducted on 64-multi-slice computed tomography (64-MSCT), where we analyzed quantitative and morphological characteristics of blood vessel-detected lesions. Patients from the control group had statistically very significant elevated cholesterol and triglyceride levels in regard to the patients with SAPS and PAPS (p < 0.001 and p < 0.05). Analyzing percentage of diameter stenosis, we have established that lesions from group with 0–30% diameter stenosis (DS) in patients with PAPS (n = 47) and SAPS (n = 39) are more common than that in control group (n = 3, p < 0.001). The incidence of lesions higher than 70% DS in control group (n = 74) was statistically significant than that in patients with SAPS (n = 74, p < 0.05), while very statistically significant than that in patients with PAPS (n = 48, p < 0.001). Analyzing the qualitative characteristics of plaques, we have established significant higher frequency of soft tissue (n = 32) and mixed lesions (n = 36) in patients with PAPS than the calcified one (n = 7, p < 0.001). Our study showed that the subclinical manifestation of changes on lower extremity arteries is more common in patients with APS. Because of its safety and accuracy, the method of choice is 64-MSCT angiography in monitoring disease progression.
Literature
1.
Lockshin MD, Sammartino LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000;43:440–3.CrossRefPubMed
2.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.CrossRefPubMed
3.
Shoenfeld Y, Sherer Y, Haratz D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001;22:293–5.CrossRefPubMed
4.
Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V. Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis. 2005;64:315–7.CrossRefPubMed
5.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498.CrossRefPubMed
6.
Rovensky J. Asheron’s syndrome—catastrophic antipospholipid syndrome. Autoimmun Rev. 2006;6:61–3.CrossRefPubMed
7.
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. Isr Med Assoc J. 2008;10(1):8–12.PubMed
8.
Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.CrossRefPubMed
9.
Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6(6):379–86.CrossRefPubMed
10.
Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D. Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev. 2010;10:235–7.CrossRefPubMed
11.
Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics. 2004;24(4):1069–86.CrossRefPubMed
12.
Kaushik S, Federle M, Schur PH, Krishnan M, Silverman SG, Ros PR. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology. 2001;218:768–7.CrossRefPubMed
13.
Beregi JP, Djabbari M, Desmoucelle F, Willoteaux S, Wattinne L, Louvegini S. Popliteal vascular disease: evaluation with spiral CT angiography. Radiology. 1997;203:477–83.CrossRefPubMed
14.
Verbeeck N, Cavez N, Plawny L, Weber J, Lens V. Primary aortic thrombosis: role of enhanced multislice CT demonstrated in three exceptional cases. JBR-BTR. 2014;97(2):76–80.PubMed
15.
Suzuki K, Uemura T, Kikuchi M, Ishihara Y, Ichioka S. Acute limb-threatening ischemia associated with antiphospholipid syndrome: a report of two cases. J Foot Ankle Surg. 2016;55(6):1318–22.CrossRefPubMed
16.
Crome CR, Rajagopalan S, Kuhan G, Fluck N. Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Rep. 2012;20:2012.
17.
Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S, Carerj S, Turiel M. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev. 2009;8(4):281–6.CrossRefPubMed
18.
Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, Lammer J, Minar E, Loewe C. Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis—findings from a randomized controlled trial. Eur J Radiol. 2012;81(9):2265–9.CrossRefPubMed
19.
Laswed T, Rizzo E, Guntern D, Doenz F, Denys A, Schnyder P, Qanadli SD. Assessment of occlusive arterial disease of abdominal aorta and lower extremities arteries: value of multidetector CT angiography using an adaptive acquisition method. Eur Radiol. 2008;18(2):263–72.CrossRefPubMed
20.
Nardi P, Pellegrino A, Romagnoli A, Mve Mvondo C, De Propris S, Sperandio M, Versaci F, Simonetti G, Chiariello L. Multidetector computed tomographic coronary angiography as an alternative to conventional coronary angiography in non-coronary surgical patients. J Cardiovasc Surg. 2011;52(3):429–35.
21.
Van den Bosch H, Westenberg J, Setz-Pels W, Kersten E, Tielbeek A, Duijm L, Post J, Teijink J, de Roos A. Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study. Int J Cardiovasc Imaging. 2016;32:1281–8.CrossRefPubMed
22.
Lin YH, Lin HH, Liu HM, Lee CW, Chen YF. Diagnostic performance of CT and MRI on the detection of symptomatic intracranial dural arteriovenous fistula: a meta-analysis with indirect comparison. Neuroradiology. 2016;58:753–63.CrossRefPubMed
23.
Cina A, Di Stasi C, Semeraro V, Marano R, Savino G, Iezzi R, Bonomo L. Comparison of CT and MR angiography in evaluation of peripheral arterial disease before endovascular intervention. Acta Radiol. 2016;57(5):547–56.CrossRefPubMed
Metadata
Title
The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome
Authors
Jovica Saponjski
Ljudmila Stojanovich
Jelena Petrovic
Dusan Saponjski
Publication date
01-04-2017
Publisher
Springer US
Published in
Immunologic Research / Issue 2/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8887-6

Other articles of this Issue 2/2017

Immunologic Research 2/2017 Go to the issue

Novel Aspects in Lupus, 2017

Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features

Novel Aspects in Lupus, 2017

The microbiome and systemic lupus erythematosus

Novel Aspects in Lupus, 2017

Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus

Novel Aspects in Lupus, 2017

HPV and systemic lupus erythematosus: a mosaic of potential crossreactions

Novel Aspects in Lupus, 2017

Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study

Novel Aspects in Lupus, 2017

Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls